cyclosporine + prednisolone acetate

Cyclosporine + prednisolone acetate is a **combination therapy** of two immunosuppressive and anti-inflammatory agents. **Cyclosporine** is a calcineurin inhibitor that suppresses T-cell mediated immune responses by inhibiting the transcription of interleukin-2 and other cytokines. **Prednisolone acetate** is a synthetic glucocorticoid corticosteroid that primarily acts by binding to the glucocorticoid receptor, altering gene expression, and reducing inflammation and immune activity. This combination is used systemically (primarily oral or, for prednisolone acetate, also topical/ophthalmic) for various autoimmune disorders and nephrotic syndromes, and has also been studied topically (ophthalmic) for ocular inflammatory disorders like dry eye and herpetic stromal keratitis. The combination is not marketed as a unique fixed-dose product but is frequently co-prescribed, reflecting additive or synergistic immunosuppressive/anti-inflammatory effects[5][3].